RELAFEN DS 1000 mg/1
NABUMETONE · TABLET · Carwin Pharmaceutical Associates, LLC
No Recall History
Plain English
RELAFEN DS is a tablet containing nabumetone at 1000 mg/1, taken oral. Manufactured by Carwin Pharmaceutical Associates, LLC.
Key Facts
- Brand Name
- RELAFEN DS
- Generic Name
- NABUMETONE
- NDC Code (Product)
15370-170- Manufacturer
- Carwin Pharmaceutical Associates, LLC
- Strength
- 1000 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA203166
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]
- Marketing Start
- 09/20/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is RELAFEN DS used for?
RELAFEN DS contains NABUMETONE. It is a tablet taken oral. Consult your doctor for specific uses.
Is RELAFEN DS a controlled substance?
RELAFEN DS is not classified as a controlled substance by the DEA.
What is the generic name for RELAFEN DS?
The generic name for RELAFEN DS is NABUMETONE. There are 11 other brand versions of NABUMETONE.
What is the NDC code for RELAFEN DS 1000 mg/1?
The NDC (National Drug Code) for RELAFEN DS 1000 mg/1 is 15370-170, listed by Carwin Pharmaceutical Associates, LLC.